Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses

MLA

Mo-Yuan Quan, et al. “Amlexanox Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Dendritic Cell Maturation and Reprogramming Effector and Regulatory T Cell Responses.” Journal of Neuroinflammation, vol. 16, no. 1, Mar. 2019, pp. 1–17. EBSCOhost, https://doi.org/10.1186/s12974-019-1438-z.

APA

Mo-Yuan Quan, Xiu-Juan Song, Hui-Jia Liu, Xiao-Hong Deng, Hui-Qing Hou, Li-Ping Chen, Tian-Zhao Ma, Xu Han, Xin-Xin He, Zhen Jia, & Li Guo. (2019). Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses. Journal of Neuroinflammation, 16(1), 1–17. https://doi.org/10.1186/s12974-019-1438-z

Chicago

Mo-Yuan Quan, Xiu-Juan Song, Hui-Jia Liu, Xiao-Hong Deng, Hui-Qing Hou, Li-Ping Chen, Tian-Zhao Ma, et al. 2019. “Amlexanox Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Dendritic Cell Maturation and Reprogramming Effector and Regulatory T Cell Responses.” Journal of Neuroinflammation 16 (1): 1–17. doi:10.1186/s12974-019-1438-z.